» Articles » PMID: 12745060

Signal Transduction by Receptor Activator of Nuclear Factor Kappa B in Osteoclasts

Overview
Publisher Elsevier
Specialty Biochemistry
Date 2003 May 15
PMID 12745060
Citations 117
Authors
Affiliations
Soon will be listed here.
Abstract

Receptor activator of nuclear factor kappa B (RANK) is a tumor necrosis factor receptor (TNFR) family protein that plays an important role in the regulation of bone and immune systems. Cellular responses to RANK ligand (RANKL) and the signal transduction pathways of RANK have been well characterized in osteoclasts and osteoclast precursor cells. RANKL induces the differentiation of osteoclast precursor cells and stimulates the resorption function and survival of mature osteoclasts. The RANK signaling mechanisms involved in these responses include the recruitment of TNF receptor-associated factor proteins, the activation of transcription factors (NF-kappaB, AP-1, and NFAT2), the cascades of mitogen-activated protein kinases (ERK, JNK, and p38), and the induction of Src- and phosphatidylinositol 3-kinase-dependent Akt activation. Despite the identification of several molecular targets, a comprehensive understanding of RANK signaling requires further studies on more complicated issues such as the temporal and spatial pattern of the engagement of signaling molecules and the precise relationship between the signaling pathway and the cellular response.

Citing Articles

Phospholipase C β4 promotes RANKL-dependent osteoclastogenesis by interacting with MKK3 and p38 MAPK.

Lee D, Jin X, Choi P, Cui Y, Che X, Lee S Exp Mol Med. 2025; 57(2):323-334.

PMID: 39894822 PMC: 11873240. DOI: 10.1038/s12276-025-01390-8.


Membrane-free stem cell components suppress osteoclast differentiation: Implications for oral regenerative treatment.

Ahn S, Kim E, Kim M, Shin S, Kwon J J Dent Sci. 2025; 20(1):212-219.

PMID: 39873034 PMC: 11762959. DOI: 10.1016/j.jds.2024.08.005.


Garcinone C attenuates RANKL-induced osteoclast differentiation and oxidative stress by activating Nrf2/HO-1 and inhibiting the NF-kB signaling pathway.

Ji H, Pan Q, Cao R, Li Y, Yang Y, Chen S Heliyon. 2024; 10(3):e25601.

PMID: 38333852 PMC: 10850749. DOI: 10.1016/j.heliyon.2024.e25601.


Applications of honeybee-derived products in bone tissue engineering.

Korani S, Khalesi N, Korani M, Jamialahmadi T, Sahebkar A Bone Rep. 2024; 20:101740.

PMID: 38304620 PMC: 10831168. DOI: 10.1016/j.bonr.2024.101740.


The miR-19a/Cylindromatosis Axis Regulates Pituitary Adenoma Bone Invasion by Promoting Osteoclast Differentiation.

Lei Z, Wang Q, Jiang Q, Liu H, Xu L, Kang H Cancers (Basel). 2024; 16(2).

PMID: 38254792 PMC: 10813535. DOI: 10.3390/cancers16020302.